US Psych Congress
Results indicate there is an unmet need for better treatment to manage symptom burden in US adults with ADHD.
Researchers sought to examine the most efficacious treatment for clinical remission in adults with schizophrenia.
Patients with MDD with or without sexual dysfunction were evaluated 2 months in remission and assessed with the Arizona Sexual Experience Scale.
Cariprazine treatment is associated with significantly higher rates of long-term sustained remission in patients with schizophrenia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Distinct Characteristics in Children at Risk for Schizophrenia vs Bipolar Disorder
- Nonstimulants May Be an Appropriate Alternative to Stimulants for Treating ADHD
- Psychotic Experiences Associated With Increased Risk for Eating Disorders in Adolescents
- Novel Parent-Child Interaction Therapy Targets Preschool-Aged Depression
- Remission of Treatment-Resistant Depression in Veterans Depends on Close Clinical Observation
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations
- From Abused Child to Serial Killer: Investigating Nature vs Nurture in Methods of Murder
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- Classification Models for Diagnosing Schizophrenia With MRI Neuroimaging
- Sodium Valproate May Lower Amygdala Volume in Pediatric Bipolar Disorder
- Putting Patients in the Physician's Seat: Smartphone Technology Is Changing the Healthcare Landscape
- Unhealthy Food Behaviors May Signal Eating Disorder in Teens
- As Immigration Policies Tighten, Physician Shortage Concerns Grow